AI assistant
Sending…
PROKIDNEY CORP. — Director's Dealing 2023
Jul 25, 2023
32485_dirs_2023-07-25_0cf0c725-7c89-4a2b-9a01-043ae4a3df21.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: PROKIDNEY CORP. (PROK)
CIK: 0001850270
Period of Report: 2023-07-17
Reporting Person: Culleton Bruce (EVP, Clinical Development)
More from PROKIDNEY CORP.
Regulatory Filings
2026
May 29
Regulatory Filings
2026
May 15
Interim / Quarterly Report
2026
May 15
Annual Report
2026
Apr 17
Regulatory Filings
2026
Mar 18
Regulatory Filings
2026
Mar 18
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3